HLOSF
Price
$1.94
Change
-$0.00 (-0.00%)
Updated
Mar 7 closing price
Capitalization
153.66M
SLN
Price
$2.61
Change
-$0.13 (-4.74%)
Updated
Apr 4 closing price
Capitalization
120.42M
Ad is loading...

HLOSF vs SLN

Header iconHLOSF vs SLN Comparison
Open Charts HLOSF vs SLNBanner chart's image
HEALIOS K K
Price$1.94
Change-$0.00 (-0.00%)
Volume$5.1K
Capitalization153.66M
Silence Therapeutics
Price$2.61
Change-$0.13 (-4.74%)
Volume$239.38K
Capitalization120.42M
HLOSF vs SLN Comparison Chart
Loading...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HLOSF vs. SLN commentary
Apr 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLOSF is a Hold and SLN is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 06, 2025
Stock price -- (HLOSF: $1.94 vs. SLN: $2.61)
Brand notoriety: HLOSF and SLN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HLOSF: 196% vs. SLN: 90%
Market capitalization -- HLOSF: $153.66M vs. SLN: $120.42M
HLOSF [@Biotechnology] is valued at $153.66M. SLN’s [@Biotechnology] market capitalization is $120.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HLOSF’s FA Score shows that 0 FA rating(s) are green whileSLN’s FA Score has 1 green FA rating(s).

  • HLOSF’s FA Score: 0 green, 5 red.
  • SLN’s FA Score: 1 green, 4 red.
According to our system of comparison, both HLOSF and SLN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SLN’s TA Score shows that 4 TA indicator(s) are bullish.

  • SLN’s TA Score: 4 bullish, 4 bearish.

Price Growth

HLOSF (@Biotechnology) experienced а 0.00% price change this week, while SLN (@Biotechnology) price change was -24.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.00%. For the same industry, the average monthly price growth was -16.69%, and the average quarterly price growth was -18.23%.

Reported Earning Dates

SLN is expected to report earnings on May 14, 2024.

Industries' Descriptions

@Biotechnology (-11.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HLOSF($154M) has a higher market cap than SLN($120M). HLOSF YTD gains are higher at: 43.704 vs. SLN (-62.064). SLN has higher annual earnings (EBITDA): -48.99M vs. HLOSF (-2.39B). HLOSF has more cash in the bank: 8.89B vs. SLN (147M). SLN has less debt than HLOSF: SLN (117K) vs HLOSF (6.1B). HLOSF has higher revenues than SLN: HLOSF (521M) vs SLN (43.3M).
HLOSFSLNHLOSF / SLN
Capitalization154M120M128%
EBITDA-2.39B-48.99M4,887%
Gain YTD43.704-62.064-70%
P/E RatioN/AN/A-
Revenue521M43.3M1,203%
Total Cash8.89B147M6,050%
Total Debt6.1B117K5,212,821%
TECHNICAL ANALYSIS
Technical Analysis
SLN
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend about 1 month ago
90%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Ad is loading...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GMOEX23.94N/A
N/A
GMO Emerging Markets III
CPODX41.29N/A
N/A
Morgan Stanley Insight I
FIEZX12.03N/A
N/A
Fidelity Advisor Total Intl Equity Z
NCVLX11.32N/A
N/A
Nuance Concentrated Value Institutional
ARTJX15.72-0.82
-4.96%
Artisan International Small-Mid Investor

HLOSF and

Correlation & Price change

A.I.dvisor tells us that HLOSF and BRTX have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HLOSF and BRTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLOSF
1D Price
Change %
HLOSF100%
N/A
BRTX - HLOSF
23%
Poorly correlated
-5.55%
LGVN - HLOSF
22%
Poorly correlated
-3.45%
ENTBF - HLOSF
7%
Poorly correlated
N/A
CPMV - HLOSF
5%
Poorly correlated
-2.99%
SLN - HLOSF
3%
Poorly correlated
-4.74%
More

SLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLN has been loosely correlated with CLLS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SLN jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLN
1D Price
Change %
SLN100%
-4.74%
CLLS - SLN
43%
Loosely correlated
-4.17%
RCKT - SLN
41%
Loosely correlated
-7.91%
CMVLF - SLN
38%
Loosely correlated
N/A
NTLA - SLN
37%
Loosely correlated
-3.77%
IDYA - SLN
37%
Loosely correlated
-5.52%
More